CTX310 for homozygous familial hypercholesterolemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Jun 2024: Trial started, NCT07491172
  2. 24 Mar 2026: Trial registered, NCT07491172

The trials

NCT07491172: A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

State
Under way
Phase
Phase 1
People
90 planned
Started
21 Jun 2024
Primary completion
Jun 2027
Arms
CTX310
Results
None posted
  1. 21 Jun 2024: Trial started
  2. 24 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.